PembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1953卷 / 1期

关键词：

D O I：

10.1007/s40278-023-37770-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：335 / 335

相关论文

共 50 条

[41] Axitinib/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 81 - 81
[42] Catequentinib/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 138 - 138
[43] Entinostat/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 595 - 595
[44] Dacarbazine/pembrolizumabLack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 170 - 170
[45] Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1935 (1) : 347 - 347
[46] Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 759 - 759
[47] PembrolizumabLack of efficacy and hypothyroidism: case report
Reactions Weekly, 2023, 1950 (1) : 330 - 330
[48] Dexamethasone/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1970 (1) : 116 - 116
[49] Antineoplastics/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1919 (1) : 91 - 91
[50] Paclitaxel/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 403 - 403

← 1 2 3 4 5 →